Evernorth: Stable Growth Supports Hold, But Upside Is Modest
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
Evernorth Group, Inc. (EVRG) is a diversified healthcare services company that appears slightly undervalued based on a DCF analysis, supported by stable growth and strong margin performance.
Investment Recommendation
Hold
Fair Value: $59.15
Current Price: $55.00
Upside/Downside: +7.5%
The DCF analysis suggests an implied fair value slightly above the current market price, indicating mild undervaluation. However, given the inherent regulatory uncertainty in the healthcare sector, a 'Hold' recommendation is prudent while awaiting clearer guidance on future PBM profitability.
Key Metrics
- Market Cap: $112.75B
- P/E Ratio: 18.5x
- Forward P/E: 15.5x
- Revenue Growth (YoY): 7.5%
- Net Margin: 3.8%
- ROE: 14.5%
- Debt/Equity: 0.80
- Dividend Yield: 2.3%
Strengths
- Strong revenue diversification across insurance, PBM, and specialized care segments, providing natural hedges against market volatility.
- Consistent operational efficiency, evidenced by a net margin stability around 3.8-4.0% in recent years.
- Good return on equity (ROE) averaging over 14%, indicating efficient capital deployment.
- Stable dividend yield of approximately 2.3%, attracting income-focused investors.
Risk Factors
- High exposure to regulatory changes within US healthcare reform, which could impact reimbursement rates and PBM profitability.
- Substantial debt burden (Debt/Equity of 0.80) requiring careful refinancing risk management.
- Intense competition, particularly in the PBM space, putting pressure on pricing power.